Страна: Австралия
Език: английски
Източник: Department of Health (Therapeutic Goods Administration)
amoxicillin trihydrate, Quantity: 1004.43 mg (Equivalent: amoxicillin, Qty 875 mg); potassium clavulanate, Quantity: 148.91 mg (Equivalent: clavulanic acid, Qty 125 mg)
Aspen Pharmacare Australia Pty Ltd
Tablet, film coated
Excipient Ingredients: microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate; sodium starch glycollate; titanium dioxide; hypromellose; macrogol 6000; macrogol 4000
Oral
60 tablets, 10 tablets, 2 tablets
(S4) Prescription Only Medicine
Augmentin Duo Forte is indicated for the short term treatment of bacterial infections at the following sites when caused by sensitive organisms (refer to Microbiology) *Urinary tract infections (uncomplicated and complicated); *Lower respiratory tract infections, including community acquired pneumonia and acute exacerbations of chronic bronchitis; *Upper respiratory tract infections, such as sinusitis, otitis media and recurrent tonsillitis; *Skin and skin structure infection Appropriate culture and susceptibility studies should be performed to identify the causative organism(s) and determine its (their) susceptibility to Augmentin Duo Forte. However when there is reason to believe an infection may involve any of the beta-lactamase producing organisms listed in the product information, therapy may be instituted prior to obtaining the results of bacteriological and susceptibility studies. Once the results are known, therapy should be adjusted should be adjusted if appropriate. The treatment of mixed infections caused by amoxycillin susceptible organisms and beta-lactamase producing organisms susceptible to Augmentin Duo Forte should not require the addition of another antibiotic due to the amoxycillin content of Augmentin Duo Forte.
Visual Identification: a white to off-white capsule-shaped film coated tablet, monogrammed with an 'A' and 'C' and a breakline on one side and 'A' and 'C' only on the other side.; Container Type: Blister Pack; Container Material: PVC/PVDC; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius
Licence status A
1998-01-08
1 AUGMENTIN ® DUO & AUGMENTIN ® DUO FORTE TABLETS _Amoxicillin trihydrate & Potassium clavulanate _ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? Please read this leaflet carefully before you take AUGMENTIN DUO or AUGMENTIN DUO FORTE tablets. This leaflet answers some common questions about AUGMENTIN DUO and AUGMENTIN DUO FORTE tablets. It does not contain all of the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Sometimes new risks are found even when a medicine has been used for many years. Your doctor has weighed the expected benefits of you taking AUGMENTIN tablets against the risks this medicine could have for you. If you have any concerns about taking this medicine, ask your doctor or pharmacist. Keep this leaflet with the medicine. You may need to read it again. WHAT ARE AUGMENTIN DUO AND AUGMENTIN DUO FORTE TABLETS USED FOR? AUGMENTIN tablets contain two active ingredients. One of these is a penicillin called amoxicillin and the other is clavulanic acid. AUGMENTIN tablets belong to the penicillin group of antibiotics. AUGMENTIN tablets are used for the short term treatment of a wide range of infections caused by bacteria. These infections may affect the chest (e.g. bronchitis or pneumonia), bladder (e.g. cystitis), sinuses (e.g. sinusitis), the ears (e.g. otitis media) or the skin. AUGMENTIN tablets work by killing the bacteria that cause these infections. AUGMENTIN tablets will not work against infections caused by viruses such as colds or the flu. Your doctor may prescribe AUGMENTIN tablets for another use. If you want more information, ask your doctor. There is no evidence that AUGMENTIN tablets are addictive. BEFORE YOU TAKE AUGMENTIN DUO OR AUGMENTIN DUO FORTE TABLETS _ _ _DO NOT TAKE AUGMENTIN _ _TABLETS IF: _ • you have had an allergic reaction to penicillin or similar types of antibiotics (such as cephalosporins) or any of the ingredients contained in AUGMENTIN DUO or AUGMENTIN DUO FORTE tablets. The in Прочетете целия документ
Augmentin-tablets-pi 1 AUSTRALIAN PRODUCT INFORMATION AUGMENTIN ® DUO AND AUGMENTIN ® DUO FORTE (AMOXICILLIN TRIHYDRATE AND POTASSIUM CLAVULANATE) TABLETS 1 NAME OF THE MEDICINE Amoxicillin Trihydrate and Potassium Clavulanate 2 QUALITATIVE AND QUANTITATIVE COMPOSITION AUGMENTIN DUO and AUGMENTIN DUO FORTE tablets (AUGMENTIN TABLETS) are combination products containing the semisynthetic antibiotic, amoxicillin (as the trihydrate) and the β -lactamase inhibitor, potassium clavulanate (as the potassium salt of clavulanic acid). Each AUGMENTIN DUO FORTE Tablet contains 875mg amoxicillin as the trihydrate and 125mg clavulanic acid as the potassium salt. Each AUGMENTIN DUO Tablet contains 500mg amoxicillin as the trihydrate and 125mg clavulanic acid as the potassium salt. For the full list of excipients, see 6.1 LIST OF EXCIPIENTS. 3 PHARMACEUTICAL FORM AUGMENTIN DUO FORTE TABLETS: A white to off-white capsule shaped film coated tablet, debossed with “AC” and a scoreline on one side and “AC” only on the other side. AUGMENTIN DUO TABLETS: A white, oval shaped, biconvex film coated tablet debossed with “AC” and a scoreline on one side and plain on the other. The scoreline is only to facilitate breaking for ease of swallowing and not to divide into equal doses. 4 CLINICAL PARTICULARS 4.1 T HERAPEUTIC INDICATIONS AUGMENTIN TABLETS are indicated for short term treatment of bacterial infections at the following sites when caused by sensitive organisms (refer to Microbiology): Urinary Tract Infections (uncomplicated and complicated) Lower Respiratory Tract Infections, including community acquired pneumonia and acute exacerbations of chronic bronchitis Upper Respiratory Tract Infections, such as sinusitis_, _ otitis media and recurrent tonsillitis Skin and Skin Structure Infection. Augmentin-tablets-pi 2 Appropriate culture and susceptibility studies should be performed to identify the causative organism(s) and determine its (their) susceptibility to AUGMENTIN TABLETS. However, when there is reason Прочетете целия документ